{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:39:56Z","timestamp":1786991996285,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004168","name":"Universit\u00e4t zu L\u00fcbeck","doi-asserted-by":"publisher","award":["J13-2022"],"award-info":[{"award-number":["J13-2022"]}],"id":[{"id":"10.13039\/501100004168","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2167\/1"],"award-info":[{"award-number":["EXC 2167\/1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TI-3"],"award-info":[{"award-number":["TI-3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jdermsci.2024.03.009","type":"journal-article","created":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T05:20:45Z","timestamp":1711171245000},"page":"64-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Anti-BP230 IgE autoantibodies in bullous pemphigoid intraindividually correlate with disease activity"],"prefix":"10.1016","volume":"114","author":[{"given":"Shirin","family":"Emtenani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beke E.","family":"Linnemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Recke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anabelle","family":"von Georg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Goletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"van Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jdermsci.2024.03.009_bib1","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/jdv.17107","article-title":"Incidence of pemphigoid diseases in Northern Germany in 2016 - first data from the Schleswig-Holstein Registry of Autoimmune Bullous Diseases","volume":"35","author":"van Beek","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"24","key":"10.1016\/j.jdermsci.2024.03.009_bib2","first-page":"413","article-title":"Bullous autoimmune dermatoses-clinical features, diagnostic evaluation, and treatment options","volume":"118","author":"Beek","year":"2021","journal-title":"Dtsch Arztebl Int."},{"issue":"9863","key":"10.1016\/j.jdermsci.2024.03.009_bib3","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jdermsci.2024.03.009_bib4","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.4049\/jimmunol.151.10.5742","article-title":"Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain","volume":"151","author":"Giudice","year":"1993","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.jdermsci.2024.03.009_bib5","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archdermatol.2011.23","article-title":"Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients","volume":"147","author":"Charneux","year":"2011","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jdermsci.2024.03.009_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2009.04630.x","article-title":"Evaluation of a new ELISA assay for detection of BP230 autoantibodies in bullous pemphigoid","volume":"1173","author":"Tampoia","year":"2009","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"2","key":"10.1016\/j.jdermsci.2024.03.009_bib7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000337545","article-title":"The value of BP230 enzyme-linked immunosorbent assay in the diagnosis and immunological follow-up of bullous pemphigoid","volume":"224","author":"Le Sache-de Peufeilhoux","year":"2012","journal-title":"Dermatology"},{"issue":"11","key":"10.1016\/j.jdermsci.2024.03.009_bib8","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/jdv.18414","article-title":"Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large, prospective cohort study","volume":"36","author":"Dikmen","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.jdermsci.2024.03.009_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2007.08.008","article-title":"Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid","volume":"49","author":"Ishiura","year":"2008","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"10.1016\/j.jdermsci.2024.03.009_bib10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archdermatol.2007.9","article-title":"Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid","volume":"144","author":"Iwata","year":"2008","journal-title":"Arch. Dermatol."},{"issue":"1","key":"10.1016\/j.jdermsci.2024.03.009_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/bjd.15114","article-title":"Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid","volume":"177","author":"Hashimoto","year":"2017","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.jdermsci.2024.03.009_bib12","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/bjd.16553","article-title":"Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score","volume":"179","author":"Holtsche","year":"2018","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.jdermsci.2024.03.009_bib13","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0923-1811(02)00109-3","article-title":"BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid","volume":"30","author":"Kobayashi","year":"2002","journal-title":"J. Dermatol. Sci."},{"issue":"3","key":"10.1016\/j.jdermsci.2024.03.009_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00403-018-1817-9","article-title":"BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid","volume":"310","author":"Daneshpazhooh","year":"2018","journal-title":"Arch. Dermatol. Res."},{"issue":"2","key":"10.1016\/j.jdermsci.2024.03.009_bib15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch. Dermatol."},{"issue":"1","key":"10.1016\/j.jdermsci.2024.03.009_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamadermatol.2016.3357","article-title":"Correlation of serum levels of IgE autoantibodies against BP180 with bullous pemphigoid disease activity","volume":"153","author":"van Beek","year":"2017","journal-title":"JAMA Dermatol."},{"issue":"5","key":"10.1016\/j.jdermsci.2024.03.009_bib17","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI116856","article-title":"A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180","volume":"92","author":"Liu","year":"1993","journal-title":"J. Clin. Invest"},{"issue":"3","key":"10.1016\/j.jdermsci.2024.03.009_bib18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nm1496","article-title":"Humanization of autoantigen","volume":"13","author":"Nishie","year":"2007","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.jdermsci.2024.03.009_bib19","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.ajpath.2014.05.007","article-title":"Fcgamma receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid","volume":"184","author":"Schulze","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"25","key":"10.1016\/j.jdermsci.2024.03.009_bib20","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1073\/pnas.1721805115","article-title":"BP180 dysfunction triggers spontaneous skin inflammation in mice","volume":"115","author":"Zhang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.jdermsci.2024.03.009_bib21","article-title":"Deciphering the contribution of BP230 autoantibodies in bullous pemphigoid","volume":"11","author":"Cole","year":"2022","journal-title":"Antibodies (Basel)"},{"issue":"3","key":"10.1016\/j.jdermsci.2024.03.009_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1586\/1744666X.2016.1123092","article-title":"IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases","volume":"12","author":"van Beek","year":"2016","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.jdermsci.2024.03.009_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2015.01.013","article-title":"In vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 cases","volume":"78","author":"Moriuchi","year":"2015","journal-title":"J. Dermatol. Sci."},{"issue":"5","key":"10.1016\/j.jdermsci.2024.03.009_bib24","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1365-2133.2011.10481.x","article-title":"Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis","volume":"165","author":"Yayli","year":"2011","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.jdermsci.2024.03.009_bib25","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clim.2012.02.003","article-title":"IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses","volume":"143","author":"Fania","year":"2012","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.jdermsci.2024.03.009_bib26","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4049\/jimmunol.1001753","article-title":"FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid","volume":"187","author":"Messingham","year":"2011","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.jdermsci.2024.03.009_bib27","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/sj.jid.5700681","article-title":"IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice","volume":"127","author":"Zone","year":"2007","journal-title":"J. Invest Dermatol."},{"issue":"11","key":"10.1016\/j.jdermsci.2024.03.009_bib28","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1038\/sj.jid.5700958","article-title":"A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu\/nu mice","volume":"127","author":"Fairley","year":"2007","journal-title":"J. Invest Dermatol."},{"issue":"4","key":"10.1016\/j.jdermsci.2024.03.009_bib29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/1346-8138.15251","article-title":"Role of BP230 autoantibodies in bullous pemphigoid","volume":"47","author":"Shih","year":"2020","journal-title":"J. Dermatol."},{"issue":"3","key":"10.1016\/j.jdermsci.2024.03.009_bib30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jdcr.2020.01.002","article-title":"Increasing evidence for omalizumab in the treatment of bullous pemphigoid","volume":"6","author":"Lonowski","year":"2020","journal-title":"JAAD Case Rep."},{"issue":"9","key":"10.1016\/j.jdermsci.2024.03.009_bib31","first-page":"1077","article-title":"Diagnostik blasenbildender autoimmundermatosen","volume":"16","author":"van Beek","year":"2018","journal-title":"J. Dtsch Dermatol. Ges."},{"issue":"10","key":"10.1016\/j.jdermsci.2024.03.009_bib32","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/jdv.18220","article-title":"Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"36","author":"Borradori","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"7","key":"10.1016\/j.jdermsci.2024.03.009_bib33","first-page":"713","article-title":"S2k guideline for the diagnosis of pemphigus vulgaris\/foliaceus and bullous pemphigoid","volume":"13","author":"Schmidt","year":"2015","journal-title":"J. Dtsch Dermatol. Ges."},{"issue":"3","key":"10.1016\/j.jdermsci.2024.03.009_bib34","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaad.2011.06.032","article-title":"Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts","volume":"66","author":"Murrell","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9","key":"10.1016\/j.jdermsci.2024.03.009_bib35","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/jdv.16752","article-title":"Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)","volume":"34","author":"Joly","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"5","key":"10.1016\/j.jdermsci.2024.03.009_bib36","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1365-2133.2012.10820.x","article-title":"Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid","volume":"166","author":"Blocker","year":"2012","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.jdermsci.2024.03.009_bib37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jdermsci.2015.03.002","article-title":"IgE autoantibodies in bullous pemphigoid: supporting role, or leading player?","volume":"78","author":"Ujiie","year":"2015","journal-title":"J. Dermatol. Sci."},{"issue":"5","key":"10.1016\/j.jdermsci.2024.03.009_bib38","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jid.2020.08.031","article-title":"Autoantibodies to BPAG1e trigger experimental bullous pemphigoid in mice","volume":"141","author":"Makita","year":"2021","journal-title":"J. Invest Dermatol."},{"issue":"6","key":"10.1016\/j.jdermsci.2024.03.009_bib39","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.jaci.2018.04.006","article-title":"Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease","volume":"142","author":"Haeberle","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.jdermsci.2024.03.009_bib40","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1023\/A:1020531005776","article-title":"IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230)","volume":"18","author":"Ghohestani","year":"1998","journal-title":"J. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.jdermsci.2024.03.009_bib41","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/jdv.16996","article-title":"IgE autoantibodies in serum and skin of non-bullous and bullous pemphigoid patients","volume":"35","author":"Lamberts","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"10","key":"10.1016\/j.jdermsci.2024.03.009_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11102856","article-title":"A review of the immunologic pathways involved in bullous pemphigoid and novel therapeutic targets","volume":"11","author":"Afarideh","year":"2022","journal-title":"J. Clin. Med."},{"issue":"9","key":"10.1016\/j.jdermsci.2024.03.009_bib43","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/1346-8138.15952","article-title":"BP230 IgE autoantibodies in topical-steroid-resistant bullous pemphigoid","volume":"48","author":"Shih","year":"2021","journal-title":"J. Dermatol."},{"issue":"1","key":"10.1016\/j.jdermsci.2024.03.009_bib44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5021\/ad.2012.24.1.45","article-title":"Usefulness of enzyme-linked immunosorbent assay using recombinant BP180 and BP230 for serodiagnosis and monitoring disease activity of bullous pemphigoid","volume":"24","author":"Lee","year":"2012","journal-title":"Ann. Dermatol."},{"key":"10.1016\/j.jdermsci.2024.03.009_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/854795","article-title":"Association of autoantibodies to BP180 with disease activity in Greek patients with bullous pemphigoid","volume":"2012","author":"Patsatsi","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"9","key":"10.1016\/j.jdermsci.2024.03.009_bib46","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00403-015-1598-3","article-title":"Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid","volume":"307","author":"Bing","year":"2015","journal-title":"Arch. Dermatol. Res."},{"issue":"4","key":"10.1016\/j.jdermsci.2024.03.009_bib47","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1034\/j.1600-0625.2001.100405.x","article-title":"Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule","volume":"10","author":"Hamada","year":"2001","journal-title":"Exp. Dermatol."},{"issue":"5","key":"10.1016\/j.jdermsci.2024.03.009_bib48","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1046\/j.1523-1747.2000.00893.x","article-title":"IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230","volume":"114","author":"Skaria","year":"2000","journal-title":"J. Invest Dermatol."},{"issue":"2","key":"10.1016\/j.jdermsci.2024.03.009_bib49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1684\/ejd.2015.2719","article-title":"Clinical and immunological profiles of anti-BP230-type bullous pemphigoid: Restriction of epitopes to the C-terminal domain of BP230, shown by novel ELISAs of BP230-domain specific recombinant proteins","volume":"26","author":"Hayakawa","year":"2016","journal-title":"Eur. J. Dermatol."},{"issue":"3","key":"10.1016\/j.jdermsci.2024.03.009_bib50","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaad.2014.04.053","article-title":"Omalizumab therapy for bullous pemphigoid","volume":"71","author":"Yu","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"issue":"10","key":"10.1016\/j.jdermsci.2024.03.009_bib51","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1111\/jdv.13758","article-title":"Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literature","volume":"30","author":"Balakirski","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"3","key":"10.1016\/j.jdermsci.2024.03.009_bib52","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2008.11.035","article-title":"Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab","volume":"123","author":"Fairley","year":"2009","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181124000550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181124000550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T05:10:51Z","timestamp":1762319451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181124000550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0923181124000550"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2024.03.009","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-BP230 IgE autoantibodies in bullous pemphigoid intraindividually correlate with disease activity","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2024.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Japanese Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}